Cargando…

Reply: benefits of screening cancer patients for distress still not demonstrated

Detalles Bibliográficos
Autores principales:	Carlson, L E, Waller, A, Groff, S L, Zhong, L, Bultz, B D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593563/ https://www.ncbi.nlm.nih.gov/pubmed/23370210 http://dx.doi.org/10.1038/bjc.2013.17

Ejemplares similares

Reply: Comment on ‘Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage' – Psychological distress in patients with cancer: is screening the effective solution?
por: Carlson, L E, et al.
Publicado: (2013)

Benefits of screening cancer patients for distress still not demonstrated
por: Coyne, J C
Publicado: (2013)

Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage
por: Carlson, L E, et al.
Publicado: (2012)

Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age
por: Giese-Davis, Janine, et al.
Publicado: (2012)

Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
por: Rosario, D J, et al.
Publicado: (2013)

Patient Care and Outcomes: Why Cancer Care Should Screen for Distress, the 6(th) Vital Sign
por: Bultz, Barry D.
Publicado: (2016)

Lessons learned about virtual cancer care and distress screening in the time of COVID-19
por: Bultz, Barry D., et al.
Publicado: (2021)

Reply to ‘Sleep duration and breast cancer risk in the breast cancer detection demonstration project follow-up cohort: true associations or bias?'
por: Qian, X, et al.
Publicado: (2015)

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
por: Temesgen, Zelalem, et al.
Publicado: (2021)

Author's Reply: How to Demonstrate the Impact of Cardiac Rehabilitation on Cardio-renal Protection
por: Kitajima, Ken, et al.
Publicado: (2019)

Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
por: Ward, S E
Publicado: (2007)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Reply: Flawed methods explain the effect of mammography screening in Nijmegen
por: Verbeek, A L M, et al.
Publicado: (2011)

Comment on ‘Psychological distress in patients with cancer: is screening the effective solution?'
por: Dekker, J, et al.
Publicado: (2013)

Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2009)

Benefits of psychosocial oncology care: Improved quality of life and medical cost offset
por: Carlson, Linda E, et al.
Publicado: (2003)

Reply: Controversies on autoimmunity and prognosis in cancer
por: Whiteside, T L
Publicado: (2006)

Reply
por: DeBiasi, Roberta L.
Publicado: (2020)

Unresolved problems with distress screening
por: Fielding, R, et al.
Publicado: (2013)

Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN
por: Bolognesi, Maddalena M., et al.
Publicado: (2023)

Authors’ reply
por: Rao, Sanjay, et al.
Publicado: (2011)

Authors’ reply
por: Mishra, L D, et al.
Publicado: (2011)

Reply
por: Rokosh, Rae S., et al.
Publicado: (2022)

Reply to the letter of Braber et al.: ‘Coronary stenting versus bypass surgery in elderly with multivessel disease: long-term mortality rate is still up for debate’
por: Gimbel, M. E., et al.
Publicado: (2020)

Reply: The value of case–control audits of screening
por: Sasieni, P, et al.
Publicado: (2004)

Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer
por: Duran, I, et al.
Publicado: (2007)

Reply
por: Lokken, Erica M., et al.
Publicado: (2020)

Reply: Cancer care in rural areas
por: Campbell, N C, et al.
Publicado: (2004)

Reply: Ionising radiation and occupational cancer in Britain
por: Rushton, L, et al.
Publicado: (2012)

Authors' reply
por: Romero, Ivana L, et al.
Publicado: (2010)

Esophageal pressure-guided positive end-expiratory pressure in acute respiratory distress syndrome: The jury is still out!
por: Ray, Animesh, et al.
Publicado: (2016)

Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, D., et al.
Publicado: (2019)

Reply to the letter to the editor
por: Alio, Jorge L., et al.
Publicado: (2021)

Authors’ reply
por: Teegala, Madhai L, et al.
Publicado: (2018)

THE AUTHORS REPLY
por: Hutcheon, Jennifer A., et al.
Publicado: (2017)

Authors' Reply
por: Pennington, Justin D., et al.
Publicado: (2019)

Authors’ reply
por: Moura, Frederico Castelo, et al.
Publicado: (2010)

Authors’ reply
por: Gautam, Parshotam L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rs3arak8rnstk66p830qqd2rd8